1. Home
  2. PAHC vs BCX Comparison

PAHC vs BCX Comparison

Compare PAHC & BCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAHC
  • BCX
  • Stock Information
  • Founded
  • PAHC 1946
  • BCX 2011
  • Country
  • PAHC United States
  • BCX United States
  • Employees
  • PAHC N/A
  • BCX N/A
  • Industry
  • PAHC Biotechnology: Pharmaceutical Preparations
  • BCX Finance/Investors Services
  • Sector
  • PAHC Health Care
  • BCX Finance
  • Exchange
  • PAHC Nasdaq
  • BCX Nasdaq
  • Market Cap
  • PAHC 871.9M
  • BCX 728.0M
  • IPO Year
  • PAHC 2014
  • BCX N/A
  • Fundamental
  • Price
  • PAHC $21.36
  • BCX $9.34
  • Analyst Decision
  • PAHC Sell
  • BCX
  • Analyst Count
  • PAHC 4
  • BCX 0
  • Target Price
  • PAHC $21.00
  • BCX N/A
  • AVG Volume (30 Days)
  • PAHC 259.8K
  • BCX 370.6K
  • Earning Date
  • PAHC 05-07-2025
  • BCX 01-01-0001
  • Dividend Yield
  • PAHC 2.27%
  • BCX 6.99%
  • EPS Growth
  • PAHC 30.53
  • BCX N/A
  • EPS
  • PAHC 0.48
  • BCX N/A
  • Revenue
  • PAHC $1,106,080,000.00
  • BCX N/A
  • Revenue This Year
  • PAHC $28.33
  • BCX N/A
  • Revenue Next Year
  • PAHC $10.57
  • BCX N/A
  • P/E Ratio
  • PAHC $45.00
  • BCX N/A
  • Revenue Growth
  • PAHC 12.63
  • BCX N/A
  • 52 Week Low
  • PAHC $12.17
  • BCX $8.25
  • 52 Week High
  • PAHC $26.55
  • BCX $9.90
  • Technical
  • Relative Strength Index (RSI)
  • PAHC 42.69
  • BCX 56.67
  • Support Level
  • PAHC $21.38
  • BCX $9.29
  • Resistance Level
  • PAHC $21.93
  • BCX $9.47
  • Average True Range (ATR)
  • PAHC 0.74
  • BCX 0.13
  • MACD
  • PAHC -0.05
  • BCX 0.02
  • Stochastic Oscillator
  • PAHC 46.58
  • BCX 77.12

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About BCX BlackRock Resources of Beneficial Interest

BlackRock Resources & Commodities Strategy Trust operates as an investment trust. Its investment objective is to seek high current income and current gains, with a secondary objective of capital appreciation. The company invests at least 80% of its total assets in equity securities issued by commodity or natural resources companies, derivatives with exposure to commodity or natural resources companies or investments in securities and derivatives linked to the underlying price movement of commodities or natural resources.

Share on Social Networks: